HealthDay News — For young patients with primary multimetastatic Ewing sarcoma, pazopanib is well-tolerated and effective, according to a study published online Oct. 22 in Frontiers in Oncology.
Shanghai Pharmaceuticals Holding Co Class H (($SHPMF)) announced an update on their ongoing clinical study. Shanghai Pharmaceuticals Holding Co.
Nursery workers and their friends climbed Mount Snowden in memory of a youngster who died from cancer earlier this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback